Essa Pharma Inc. regained compliance with the Nasdaq Stock Market's minimum market value listing requirement.
The Canadian pharmaceutical company recently completed a reverse stock split to meet Nasdaq's $1 minimum required bid price.
Essa Pharma regains Nasdaq compliance
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Essa Pharma Inc. regained compliance with the Nasdaq Stock Market's minimum market value listing requirement.
The Canadian pharmaceutical company recently completed a reverse stock split to meet Nasdaq's $1 minimum required bid price.